Breast implants cause discomfort for reasons that range from predictable post-surgical healing to slow-developing complications that can emerge years or even decades later. Some degree of tightness, sensitivity, or pressure is normal in the months following surgery, but persistent or worsening pain often signals something worth investigating. Capsular contracture, nerve irritation, bacterial biofilm, and the weight of the implant itself each produce distinct types of discomfort, and understanding which is which helps you know when to wait and when to call your surgeon.
Capsular Contracture and Why It Is the Most Common Culprit
Your body forms a thin layer of scar tissue around any foreign object it encounters, and breast implants are no exception. This capsule is actually a normal response. Problems start when the capsule thickens and tightens, squeezing the implant and distorting the breast. That process is called capsular contracture, and it is the single most frequent source of chronic implant-related discomfort.
Surgeons grade capsular contracture on the Baker scale, from I (soft, normal-feeling breast) through IV (hard, painful, and visibly distorted). Research using ultrasound measurements has shown that capsule thickness increases with Baker grade, averaging around 0.6 mm in grade I and climbing to roughly 1.5 mm or more in grades III and IV. Higher-grade contractures are also about five times more likely to show abnormal wrinkling of the implant surface compared to lower grades.1PubMed Central. Ultrasound Criteria and Baker Scale for Breast Implant Capsular Contracture Diagnosis Despite being widely used, the Baker scale has well-documented limitations. Patient-reported outcomes sometimes do not line up well with the clinical grade a surgeon assigns, which means you can feel significant discomfort even at a grade that looks mild on paper.2PubMed. Histopathological Scoring Improves the Correlation Between Capsular Contracture Diagnosis and Patient-Reported Outcomes
At the cellular level, the thickening is driven by cells called myofibroblasts, which lay down excessive contractile scar tissue under the influence of signaling molecules in the body. Researchers are actively working on drugs that block myofibroblast formation, though these treatments are still experimental.3PubMed Central. Discovery of Novel Small Molecules that Block Myofibroblast Formation: Implications for Capsular Contracture Treatment For now, if capsular contracture progresses to the point of significant pain or breast distortion, the standard treatment is surgical removal of the capsule with or without implant replacement.
How Implant Placement Affects Discomfort
Where the implant sits inside the chest wall makes a real difference in what kind of discomfort you experience. The two main positions are prepectoral (in front of the chest muscle) and subpectoral (partly or fully behind it). Each comes with trade-offs.
Subpectoral placement has been the traditional choice because the muscle provides extra coverage over the implant, which can make results look more natural in thin patients. The downside is that the pectoralis major muscle sits directly on top of the implant, which means every time you flex your chest, the muscle pushes against the implant. This produces a phenomenon called animation deformity, where the breast visibly shifts or distorts when you use your arms. It can also cause a pulling, cramping sensation during exercise or even simple movements like pushing a door open.
A systematic review comparing the two positions found that prepectoral placement significantly reduced both animation deformity and early postoperative pain compared with subpectoral placement.4Sapienza: International Journal of Interdisciplinary Studies. Efficacy and safety of prepectoral versus subpectoral implant-based breast reconstruction: a systematic review If you are someone who exercises frequently, lifts weights, or has a physically demanding job, and your implants sit behind the muscle, animation-related discomfort is a common and persistent complaint. Switching to a prepectoral position during revision surgery is one way surgeons address it.
Nerve Irritation and Chronic Pain Syndromes
Breast surgery of any kind involves cutting through tissue that contains sensory nerves. The intercostal nerves that supply feeling to the breast and nipple can be stretched, compressed, or severed during implant placement. In many people, nerve function recovers over several months. In others, it does not, and chronic pain develops.
Post-breast-surgery pain syndrome is a recognized condition that affects a substantial fraction of patients. Estimates of its prevalence range widely, from about 20 to 60 percent, depending on the type of surgery, the definition of chronic pain used, and how long after surgery patients are evaluated.5PubMed Central. Re-visiting post-breast surgery pain syndrome: risk factors, peripheral nerve associations and clinical implications The pain is typically described as burning, shooting, or a deep ache along the side of the chest or under the arm. It tends to be different from the pressure-like discomfort of capsular contracture, feeling more electrical or nerve-like.
Understanding which peripheral nerve is responsible for transmitting the pain can help surgeons tailor treatment. Options range from medications that calm nerve activity to targeted nerve blocks or surgical revision. If your pain has a shooting or burning quality, especially along the ribs or armpit area, it is worth asking whether nerve involvement might be the explanation rather than assuming it is just “normal” implant discomfort.
Bacterial Biofilm and the Inflammation It Drives
One of the more underappreciated causes of implant discomfort is bacterial biofilm, a thin layer of bacteria that attaches to the implant surface and shields itself from both your immune system and antibiotics. These biofilms form at the time of surgery when tiny numbers of bacteria from the skin or breast ducts colonize the implant. They do not always cause an acute infection, which is why they can go undetected for years while quietly provoking chronic low-grade inflammation in the surrounding capsule.
A systematic review of the microbiota associated with capsular contracture found that the bacteria most commonly isolated from contracted capsules were Staphylococcus epidermidis, Cutibacterium acnes (formerly called Propionibacterium acnes), and Streptococcus species. The presence of these biofilms has been linked to the chronic inflammation and fibrosis that drives capsular contracture forward.6PubMed Central. Association Between Breast Microbiota and Capsular Contracture: A Systematic Review Research has also connected biofilm abundance to broader systemic symptoms. In one study, Staphylococcus epidermidis colonization was found in about 73 percent of patients experiencing breast implant illness symptoms, compared with roughly 17 percent of implant patients without those symptoms.7PubMed Central. Biofilm-derived oxylipin 10-HOME–mediated immune response in women with breast implants
This is why surgeons take contamination prevention seriously during implant placement, using techniques like irrigation with antibacterial solutions and minimizing the implant’s contact with skin before insertion. Once a biofilm is well established, antibiotics alone rarely clear it. If biofilm is suspected as the source of chronic discomfort or contracture, removing the implant and its surrounding capsule is usually the most effective option.
How Surface Texture and Implant Type Matter
Not all implants interact with your body the same way. The implant’s surface texture has a measurable effect on which complications you are more likely to encounter. Textured implants have a rough surface designed to grip surrounding tissue, while smooth implants have a polished shell that allows some movement within the pocket.
A study of over 1,000 breast reconstruction patients found that smooth implants were significantly more likely to produce visible rippling, the kind of wrinkling you can see or feel through the skin. Textured implants, on the other hand, were associated with a higher rate of cellulitis, a skin infection. In that study, about 9 percent of textured-implant recipients developed cellulitis, compared with about 5 percent of those with smooth implants.8PubMed Central. Smooth vs. Textured Implant Breast Reconstruction: Patient-Reported Outcomes and Complications Textured surfaces also carry a very small risk of breast implant-associated anaplastic large cell lymphoma, a rare cancer discussed later in this article.
Rippling is not dangerous, but it can be uncomfortable in a cosmetic sense and occasionally physically noticeable, especially when bending forward. If you have thin breast tissue covering a smooth implant, you may feel the folds through your skin. The choice between smooth and textured is one your surgeon makes based on your body type, the surgical technique, and the balance of risks.
Musculoskeletal Strain from Added Weight
Breast implants add real weight to your chest, and your spine and muscles respond accordingly. This is an aspect of discomfort that gets overlooked in discussions focused on the implant itself, because the pain shows up in your neck, shoulders, and back rather than in the breast.
A study measuring posture changes after augmentation found a significant increase in cervical lordosis, the inward curve of the neck, starting at implant sizes of about 400 grams per breast. That weight threshold appeared to break the normal postural balance of the cervical spine, and the effect held steady even with larger implants.9PubMed Central. Objective Clinical Assessment of Posture Patterns after Implant Breast Augmentation Separately, research on how breast volume affects muscle activity found that neck and trunk muscles worked significantly harder once breast volume increased beyond a certain point, which could contribute to fatigue and muscle dysfunction over time.10PubMed Central. Effects of Artificially Induced Breast Augmentation on the Electromyographic Activity of Neck and Trunk Muscles during Common Daily Movements
If you experience chronic neck stiffness, upper back pain, or shoulder tension after augmentation, the implant weight itself may be part of the picture. This is especially relevant for petite individuals who chose larger implants, and it is a factor worth discussing honestly with your surgeon before surgery. Strengthening exercises for the upper back and core can help compensate, but there is a limit to how much muscle conditioning can offset a significant weight imbalance on the front of your torso.
Breast Implant Illness
Breast implant illness (BII) refers to a collection of whole-body symptoms that some people with implants develop, including fatigue, joint pain, muscle aches, brain fog, dry eyes and mouth, and skin rashes. The condition has been controversial in medicine, in part because it lacks a single diagnostic test and because the range of reported symptoms is very broad. But the research landscape has shifted considerably in recent years.
A review of epidemiological studies found evidence linking breast implants with several autoimmune conditions, including Sjögren’s syndrome, rheumatoid arthritis, systemic sclerosis, and Raynaud’s syndrome. Explantation led to symptom improvement in over half of the patients studied.11PubMed Central. Breast Implant-Associated Immunological Disorders A more recent systematic review and meta-analysis put the improvement rate higher, with about 82 percent of patients reporting symptom improvement after explantation. Fatigue was the most commonly reported symptom (present in roughly 58 percent of BII patients), followed by joint pain (about 51 percent) and muscle pain (about 44 percent). Autoimmune conditions were present in about 21 percent of patients, and positive microbial analysis, suggesting biofilm, was found in about 35 percent.12PubMed Central. Breast Implant Illness: Symptoms, Outcomes with Explantation and Potential Etiologies-A Systematic Review and Meta-analysis
Despite these findings, the biological mechanism connecting the implant to these distant symptoms remains incompletely understood. Research into immune markers has produced mixed results. One study examining serum tryptase and IgE levels (markers sometimes associated with allergic or mast-cell-mediated reactions) found no significant change in these markers after explantation for most patients, although women who started with very high IgE levels did tend to see declines afterward.13PubMed Central. Serum tryptase and IgE before and after explantation in women with breast implant illness This does not mean BII is imaginary; it means the immune pathways involved are probably more complex than a simple allergic reaction and may involve biofilm-driven inflammation, silicone particle migration, or other mechanisms still being worked out.
When to Seek Medical Attention Promptly
Not all implant discomfort warrants an urgent call to your surgeon, but certain presentations do. A breast that suddenly becomes red, warm, and swollen needs same-day evaluation. This combination suggests an active infection, and guidelines advise starting antibiotic therapy immediately along with referral to a plastic surgeon, because delay can lead to tissue damage or implant loss.14PubMed Central. Recognizing and Managing Breast Implant Complications: A Review for Healthcare Providers Who Treat Women Who Underwent Breast Implant–Based Surgery
Other situations that justify prompt evaluation include:
- Sudden size change: A breast that grows noticeably larger over days to weeks could indicate a fluid collection, either a seroma (accumulated clear fluid) or a hematoma (blood). Late hematomas can develop many years after the original surgery, sometimes without any trauma. In one case series, late hematomas appeared 9 to 38 years after implant insertion, with at least a doubling of breast size in every patient.15PubMed Central. Late unilateral hematoma after breast augmentation
- Persistent seroma years after surgery: A late-onset fluid collection around a textured implant should raise the question of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), a rare cancer that almost always occurs with textured-surface implants. It often presents with breast pain, swelling, asymmetry, or a mass.16PubMed Central. How I treat breast implant-associated anaplastic large cell lymphoma BIA-ALCL is very rare, but catching it early dramatically improves outcomes.
- New lump or mass: Any new palpable lump near or around an implant should be evaluated with imaging, regardless of how long ago the implant was placed.
- Progressive hardening with pain: Capsular contracture that worsens steadily, rather than stabilizing, warrants assessment to rule out infection, rupture, or other underlying causes.
How Implant Problems Are Evaluated
When a complication is suspected, imaging is the primary diagnostic tool. Ultrasound and MRI are the two workhorses, and they each have strengths in different areas. A study comparing dedicated breast ultrasound to MRI found that ultrasound was better at evaluating the internal contents of the implant, the implant surface, and what was going on inside the capsule. MRI, on the other hand, was better at classifying the type and thickness of the fibrous capsule itself. For large-scale changes like fluid collections, implant position shifts, or obvious rupture, the two methods performed similarly.17PubMed Central. Dedicated Ultrasonography Versus Magnetic Resonance Imaging for Breast Implant Evaluation, Initial Study
In practice, many surgeons start with ultrasound because it is faster, cheaper, and does not require contrast dye or a closed scanner. MRI is usually reserved for cases where the ultrasound findings are unclear or when a more detailed look at the capsule is needed. The FDA recommends screening MRI or ultrasound for silicone gel implants starting five to six years after placement and then every two to three years, specifically to check for silent ruptures that you might not feel.
What Happens When Implants Are Removed
Explantation, the surgical removal of breast implants, is the definitive treatment for complications that do not respond to conservative management. The procedure is usually combined with total capsulectomy, meaning the scar capsule is removed along with the implant. This is especially important when biofilm or capsular contracture is involved, because leaving the capsule behind can leave the source of inflammation in place.
For patients with breast implant illness, the outcomes after explantation are generally favorable, though the degree of improvement varies. One prospective study of 50 patients found an 82 percent decrease in mean symptom frequency at one year, with the most dramatic improvements in fatigue, cognitive difficulty, and wound healing.18PubMed Central. Patient-Reported Symptom Changes Following Breast Implant Explantation with Total Capsulectomy: A Prospective Case Series of 50 Patients Another study reported that 96 percent of BII patients experienced improved or complete resolution of systemic symptoms after removal and capsulectomy, with all patients who had positive microbial cultures reporting improvement.19PubMed Central. Breast Implant Illness: Treatment Using Total Capsulectomy and Implant Removal
The picture gets more nuanced when you look at specific patient groups. A systematic review and meta-analysis that separated patients by diagnosis found that people with BII-type symptoms generally achieved moderate improvement after explantation, while those with autoimmune conditions linked to the ASIA framework (autoimmune/autoinflammatory syndrome induced by adjuvants) achieved only partial improvement and sometimes needed additional immunosuppressive treatment. By contrast, patients with complications like granulomas, respiratory issues, or kidney-related problems linked to silicone showed complete or near-complete recovery.20PubMed Central. Breast implant explantation and capsulectomy in symptomatic patients. Is there any improvement with the procedure? Systematic review and meta-analysis The practical implication: explantation helps most people feel better, but if a true autoimmune condition has been triggered, removing the implant may not be enough on its own.
BIA-ALCL and the Textured-Implant Connection
Breast implant-associated anaplastic large cell lymphoma is a cancer of the immune system, not of the breast tissue itself. It develops in the fluid or scar capsule surrounding the implant and has been identified almost exclusively in patients with textured-surface implants. The disease typically appears years after implant placement, with most cases presenting as a delayed seroma that comes on without an obvious cause.16PubMed Central. How I treat breast implant-associated anaplastic large cell lymphoma
The absolute risk is very low. Estimates vary, but the lifetime risk is generally quoted in the range of one in several thousand to one in roughly 30,000 depending on the specific textured implant type. When caught early and confined to the fluid and capsule, treatment involves removing the implant and complete capsulectomy, and outcomes are typically excellent. Advanced cases involving a mass or lymph node spread may require chemotherapy. Because of this risk, several countries have restricted or pulled specific textured implant brands from the market, and many surgeons have shifted toward smooth-surface devices.
If you have textured implants, there is no need for panic, but you should stay aware of the signs. Any unexplained swelling, new asymmetry, or persistent fluid accumulation more than a year after surgery deserves evaluation. A simple ultrasound can usually detect a seroma, and fluid aspirated from around the implant can be tested for the specific markers of BIA-ALCL.
How Reconstruction Patients Differ from Cosmetic Augmentation Patients
People who receive implants after mastectomy face a somewhat different comfort landscape than those who have augmentation for cosmetic reasons. Post-mastectomy patients typically have less native breast tissue covering the implant, which can make rippling, implant edge visibility, and temperature sensitivity more noticeable. Radiation therapy, which is common in breast cancer treatment, also significantly increases the risk of capsular contracture by damaging the tissue’s ability to heal normally.
Despite these challenges, research comparing aesthetic outcomes between augmentation and reconstruction patients has found that the two groups can achieve comparable results when surgical technique is optimized.21PubMed Central. Breast Augmentation and Breast Reconstruction Demonstrate Equivalent Aesthetic Outcomes The comfort profile, however, tends to differ. Reconstruction patients are more likely to experience reduced or absent nipple sensation, chronic tightness from radiation-affected tissue, and the psychological discomfort of an implant that does not feel like their original breast. These are not complications in the traditional sense, but they are real sources of daily discomfort that reconstruction patients should be prepared for and that surgeons should discuss openly before surgery.